139 related articles for article (PubMed ID: 2505732)
21. Calbindin-d(28k): a marker of recurrence for medulloblastomas.
Pelc K; Vincent S; Ruchoux MM; Kiss R; Pochet R; Sariban E; Decaestecker C; Heizmann CW
Cancer; 2002 Jul; 95(2):410-9. PubMed ID: 12124842
[TBL] [Abstract][Full Text] [Related]
22. Differentiation in the medulloblastoma. A histological and immunohistochemical study.
Burger PC; Grahmann FC; Bliestle A; Kleihues P
Acta Neuropathol; 1987; 73(2):115-23. PubMed ID: 3604579
[TBL] [Abstract][Full Text] [Related]
23. Expression of major histocompatibility complex on human medulloblastoma cells with neuronal differentiation.
Tamura K; Shimizu K; Yamada M; Okamoto Y; Matsui Y; Park KC; Mabuchi E; Moriuchi S; Mogami H
Cancer Res; 1989 Oct; 49(19):5380-4. PubMed ID: 2504489
[TBL] [Abstract][Full Text] [Related]
24. Pale islands in medulloblastoma consist of differentiated cells with low growth potential.
Iijima M; Nakazato Y
Pathol Int; 1997 Jan; 47(1):25-30. PubMed ID: 9051689
[TBL] [Abstract][Full Text] [Related]
25. Synaptophysin: a reliable marker for medulloblastomas.
Schwechheimer K; Wiedenmann B; Franke WW
Virchows Arch A Pathol Anat Histopathol; 1987; 411(1):53-9. PubMed ID: 3107209
[TBL] [Abstract][Full Text] [Related]
26. [Medulloblastoma with neuronal differentiation: a report of five cases].
Nishio S; Morioka T; Inamura T; Takeshita I; Ishihara S; Fukui M
No To Shinkei; 2000 May; 52(5):391-7. PubMed ID: 10845206
[TBL] [Abstract][Full Text] [Related]
27. Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas.
Fung KM; Rorke LB; Giasson B; Lee VM; Trojanowski JQ
Acta Neuropathol; 2003 Aug; 106(2):167-75. PubMed ID: 12783249
[TBL] [Abstract][Full Text] [Related]
28. [Glial fibrillary acidic protein and central nervous system tumors. Immunohistochemical study of a series of 207 cases. 2: Medulloblastomas. Hemangioblastomas. Other tumors. Discussion].
Pasquier B; Lachard A; Pasquier D; Couderc P; Delpech B; Courel MN
Ann Pathol; 1983 Sep; 3(3):203-11. PubMed ID: 6354202
[TBL] [Abstract][Full Text] [Related]
29. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
[TBL] [Abstract][Full Text] [Related]
30. Establishment and characterization of four human medulloblastoma-derived cell lines.
Keles GE; Berger MS; Srinivasan J; Kolstoe DD; Bobola MS; Silber JR
Oncol Res; 1995; 7(10-11):493-503. PubMed ID: 8866661
[TBL] [Abstract][Full Text] [Related]
31. Neuronal and glial proteins in medulloblastomas. II. Heterotransplantation of human medulloblastoma.
Sawa H; Takeshita I; Kuramitsu M; Egami H; Fukui M; Sato Y
Anticancer Res; 1986; 6(5):911-5. PubMed ID: 3099631
[TBL] [Abstract][Full Text] [Related]
32. [Immunohistochemical study of neoplasm-associated proteins in cerebellum medulloblastomas].
Korshunov AG; Sycheva RV; Golanov AV
Arkh Patol; 1998; 60(4):8-14. PubMed ID: 9791689
[TBL] [Abstract][Full Text] [Related]
33. Coexpression of platelet-derived growth factor alpha and beta receptors on medulloblastomas and other primitive neuroectodermal tumors is consistent with an immature stem cell and neuronal derivation.
Smits A; van Grieken D; Hartman M; Lendahl U; Funa K; Nistér M
Lab Invest; 1996 Jan; 74(1):188-98. PubMed ID: 8569181
[TBL] [Abstract][Full Text] [Related]
34. Effects of basic fibroblast growth factor on the differentiation, growth, and viability of a new human medulloblastoma cell line (UM-MB1).
Kenigsberg RL; Hong Y; Yao H; Lemieux N; Michaud J; Tautu C; Théorêt Y
Am J Pathol; 1997 Sep; 151(3):867-81. PubMed ID: 9284836
[TBL] [Abstract][Full Text] [Related]
35. Age-related immunoreactivity pattern in medulloblastoma.
Patt S; Zimmer C
Childs Nerv Syst; 1992 Sep; 8(6):326-31. PubMed ID: 1382852
[TBL] [Abstract][Full Text] [Related]
36. On the neuronal/neuroblastic nature of medulloblastomas: a tribute to Pio del Rio Hortega and Moises Polak.
Katsetos CD; Del Valle L; Legido A; de Chadarévian JP; Perentes E; Mörk SJ
Acta Neuropathol; 2003 Jan; 105(1):1-13. PubMed ID: 12471454
[TBL] [Abstract][Full Text] [Related]
37. Medulloblastoma with lipidized cells versus lipomatous medulloblastoma.
Giordana MT; Schiffer P; Boghi A; Buoncristiani P; Benech F
Clin Neuropathol; 2000; 19(6):273-7. PubMed ID: 11128619
[TBL] [Abstract][Full Text] [Related]
38. [An immunohistochemical study of tenascin expression in cerebellar medulloblastomas].
Korshunov AG; Golanov AV; Sycheva RV
Zh Vopr Neirokhir Im N N Burdenko; 1997; (4):23-7. PubMed ID: 9460893
[TBL] [Abstract][Full Text] [Related]
39. Glial fibrillary acidic protein in medulloblastoma.
Mannoji H; Takeshita I; Fukui M; Ohta M; Kitamura K
Acta Neuropathol; 1981; 55(1):63-9. PubMed ID: 7348008
[TBL] [Abstract][Full Text] [Related]
40. [Melanotic medulloblastoma. Ultrastructural and histochemical study of a case].
García-Bragado F; Cabello A; Guarch R; Ruiz de Azúa Y; Ezpeleta I
Arch Neurobiol (Madr); 1990; 53(1):8-12. PubMed ID: 2203326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
